SEC Form 4 · accession 0000874015-26-000236
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Holly B. Kordasiewicz
Officer — EVP, Chief Development Officer
Period of report
Jul 7, 2026
Accepted (ET)
Jul 9, 2026 · 6:07 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 7, 2026 | S | 362 | $84.30 | D | 22,096 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 13, 2026